Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BF2.649 dose-escalation trial for cataplexy in narcolepsy with or without modafinil
NL-OMON33083Phase 3Active, not recruiting
- Sponsor
- Bioprojet
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in narcolepsy and cataplexy comparing BF2.649 monotherapy with BF2.649 add-on modafinil (2 arms). Primary endpoint: Change from baseline in weekly cataplexy attacks. Started Oct 2009; status: active, not recruiting.
02
Drugs
pitolisantmodafinil
03
Conditions
narcolepsycataplexy
Beyond the preview
Go deeper on NL-OMON33083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33083.